Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Centrexion raises $67mm in Series D round to fund Phase III trial for pain candidate CNTX4975

Executive Summary

Pain-focused Centrexion Therapeutics Corp. raised $67mm in a Series D financing led by New Enterprise Associates. New and returning investors, including Quan Capital, ArrowMark Partners, investment funds advised by Clough Capital Partners LP, InterWest Partners, 6 Dimensions Capital, and Efung Capital also participated in the round. NEA and Quan added members to the company board.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register